|
Patrik Frei Dr. Patrik Frei is founder and CEO of Venture Valuation AG, . Venture Valuation specializes in independent, third party assessment and valuation of emerging high growth companies in such as biotechnology/life sciences, high-tech and ICT. Further, Venture Valuation runs Biotechgate. Patrik graduated from the Business University of St. Gall and at the Swiss Federal Institute of Technology, EPFL Lausanne, his dissertation topic was ”Assessment and valuation of high growth companies” . His previous occupations include CFO of a logistics company and training at several international corporations: LeCroy (Geneva, New York), Hans Merensky Holding, Swatch Group - EM Microelectronic (Marin). Patrik Frei is also a board member and founder of ineo, a holding company of the Swiss dental implant VC-backed firm Thommen Medical.
|
